AMRX Operating Cash Flow Growth
Amneal Pharmaceuticals Inc Class A · Operating Cash Flow Growth
AMRX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-42.81%period ending
AMRX TTM Cash from Operations YoY % (-72.80% → -42.81%)
Year-over-year change
High-resolution chart · PNG
AMRX operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -42.8112% | |
| -0.9964% | |
| 15.2129% | |
| 4.7663% | |
| 39.0649% | |
| 52.3502% | |
| -14.6069% | |
| 67.779% | |
| 27.0895% | |
| 138.4958% | |
| 1,537.6505% | |
| 73.2033% | |
| 105.9586% | |
| -50.3232% | |
| -91.2737% | |
| -62.1622% | |
| -60.9406% | |
| -64.4351% | |
| -36.1954% | |
| 28.072% | |
| -22.1751% | |
| 200.4273% | |
| 22,128.7977% | |
| -28.8527% | |
| 35.3248% | |
| 38.6354% | |
| -99.3186% | |
| 459.138% | |
| 248.7594% | |
| -40.1532% | |
| 6.8505% | |
| -72.7983% |